The Cannigma

AUGUST 31, 2021

The dualistic narratives of cannabis reflect the lack of a dominant narrative environment that supports the integration of cannabis into medical practice.”. The paper concluded that the “lack of a dominant narrative environment” on the efficacy of medical marijuana can represent a barrier to the implementation of medical cannabis policies.

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

MARCH 1, 2022

technology, clinical protocol, human-interaction psychology, and data science? enhance the safety and efficacy of our compounds.? . ** We are looking for this position to be based out of NYC or Boston. A fast-paced environment where you’ll?work cutting-edge?technology, in order to ?enhance Berlin is ok too. Opportunity: .

Environment 40

Environment Topical Data Safety 40

Cannabis Law Report

SEPTEMBER 18, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 52

Compliance Compliance Seed-To-Sale Data 52

Cannabis Law Report

JULY 30, 2019

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. This is the first time it is given to patients. These trials confirm safety and, importantly, establish effectiveness. From trial to market.

Medicine 40

Medicine Clinical Trials Safety Access 40

Cannabis Law Report

AUGUST 12, 2021

This regulative environment also promotes economic growth and significant medical benefits, boosting consumer safety and accessibility. Introducing cross-border electronic prescriptions could enhance patient safety and increase tracking, as the system would be used domestically and internationally.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

JUNE 9, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 66

Compliance Compliance Seed-To-Sale Data 66

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Patients benefit from a broad spectrum of cannabis products addressing various medical conditions.

Marijuana 52

Marijuana Dispensary Research and Development Supply Chain 52

Cannabis Law Report

NOVEMBER 6, 2019

Earlier this year, the FDA petitioned the industry to provide safety and efficacy data to the agency so that it may appropriately regulate products containing the increasingly popular ingredient cannabidiol, also known as CBD. UK is ranked among the top 30 campuses in the nation for LGBTQ* inclusion and safety. About ValidCare.

Hemp 45

Hemp Data Access Education 45

The Cannigma

JULY 3, 2023

Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future. They found that it could be used in sessions to promote trust and safety, helping patients to open up and process traumatic experiences.

Research and Development 46

Research and Development Environment THC Microdosing 46

The Blunt Truth

AUGUST 13, 2019

CBD is “thriving” in the current regulatory environment, but is it doing so illegally? On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The FDA is collecting data to fill these gaps.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Canna Law Blog

DECEMBER 16, 2021

Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. Qualifying medical practitioners would need to take a two-hour training course provided by the Department of Health in order to certify patients for psilocybin treatment.

Legislation 97

Legislation Treatment Therapy Conditions 97

Marijuana Lawyer Blog

FEBRUARY 9, 2020

Since its passing in 2016, Prop 64 has earmarked its entire cannabis industry tax revenue, minus regulatory costs, to supporting public health, repairing the environment, and bettering public safety. 20 percent to public safety initiatives. million in grants to support public health and safety initiatives.

Marijuana 64

Marijuana Safety Programs Dispensary 64

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. authorizes home delivery to patients. authorizes home delivery to patients. Ability to meet the overall health needs of qualified patients and safety of the public.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. authorizes home delivery to patients. authorizes home delivery to patients. Ability to meet the overall health needs of qualified patients and safety of the public.

Law 40

Law Marijuana Education Cultivation 40

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. CBD and CBG can sometimes work in similar ways — both targeting vanilloid and serotonin receptors.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. The Environment Testing business experienced very strong volumes across most geographies in Europe, with continued market share gains.

Business 105

Business Research and Development Environment Food 105

Medicinal Genomics

JUNE 10, 2020

Here are the five most important takeaways with regards to microbial testing: Aspergillus contamination is of “particular concern” especially when consumed by patients who are immunocompromised. terreus) as a particular concern for patients using cannabis, as they can cause potentially deadly infections. fumigatus, A. niger, and A.

Research and Development 52

Research and Development Patients Medicine Cannabis 52

Cannabis Law Report

JUNE 1, 2021

As we prepare for a potential world-class launch of Vicineum, I strongly believe that these leaders will not only bring diverse and invaluable expertise to our team but will also drive the Company to continue executing our mission to save and improve the lives of patients with cancer.”. CAMBRIDGE, Mass.–(BUSINESS About Sesen Bio.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Veriheal

SEPTEMBER 23, 2021

An example of the safety of iboga can be drawn from the fact that the Bwiti and Pygmy tribes have been using iboga in their rituals and ceremonies for many, many decades. The team also reaches out to previous patients several times throughout the year to check-in. Is There Any Research on Iboga and Its Medicinal Properties?

Treatment 98

Treatment Medicine Research and Development Therapy 98

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 59

Marijuana Therapy Data THC 59

SpeedWeed

APRIL 28, 2021

We will continue to prioritize creating a positive, supportive and inclusive work environment for all team members and provide our patients and customers with the excellent service they expect and deserve from Curaleaf.”. increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission.

Seed-To-Sale 52

Seed-To-Sale Dispensary Cultivation Food 52

SpeedWeed

APRIL 28, 2021

We will continue to prioritize creating a positive, supportive and inclusive work environment for all team members and provide our patients and customers with the excellent service they expect and deserve from Curaleaf.”. increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission.

Legalization 52

Legalization Seed-To-Sale Dispensary Cannabis 52

SpeedWeed

APRIL 27, 2021

We will continue to prioritize creating a positive, supportive and inclusive work environment for all team members and provide our patients and customers with the excellent service they expect and deserve from Curaleaf.”. increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission.

Seed-To-Sale 52

Seed-To-Sale Dispensary Cannabis Cultivation 52

SpeedWeed

APRIL 29, 2021

We will continue to prioritize creating a positive, supportive and inclusive work environment for all team members and provide our patients and customers with the excellent service they expect and deserve from Curaleaf.”. increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission.

Programs 52

Programs Seed-To-Sale Dispensary Cultivation 52

SpeedWeed

AUGUST 13, 2021

Safety also played a role in Holistic Industries’ decision to convert its indoor facilities to LEDs. However, Banks says humidity levels tend to creep up more with LEDs than with HPS fixtures, due in part to denser plants putting more water into the environment. And the floral structure looks really good. ” View original article.

Access 52

Access Patients Banking Cultivation 52

Greenspoon Marder Cannabis Law Group Blog

OCTOBER 8, 2019

The Center for Disease Control (CDC), the federal agency that is on the front lines for any threat to public health, works closely with FDA and state health departments to gather data and then communicates risk to the public. Findings of environmental assessments in production facilities, farms, and events identifying food safety risks.

Vaping 64

Vaping THC Supply Chain Food 64

Cannabis Law Report

MAY 12, 2022

Could doctors be punished by federal authorities for recommending marijuana to patients consistent with state law? Could groups providing marijuana to patients raise a medical necessity defense if subject to federal prosecution? Some issues concerned the reach of federal law after state reforms.

Law 52

Law Policy State Laws Environment 52

Cannabis Law Report

DECEMBER 9, 2021

The study involved 100 treatment-resistant patients and were randomized to psilocybin or the nicotine patch, each receiving the same cognitive-behavioral therapy. At 12 months, 59% of the patients who received the psilocybin treatment remained abstinent, while only 28% of those who received the nicotine patch remained abstinent.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

SEPTEMBER 13, 2021

2021 Mid-Year Market Update,” from New Frontier Data, projects revenue from the legal cannabis market will total $43 billion by the year 2025. adults, will be registered patients in medical cannabis states within that same timeframe. The report “Cannabis in the U.S. million Americans, or 2.4% Denver, CO.

Environment 103

Environment Agriculture Business Law 103

The Cannigma

JULY 9, 2023

As discussed, the ECS is integral to creating a healthy environment for the fetus during early pregnancy, playing a significant role in the development of the embryo, its implantation in the womb, the development of the placenta, and the formation of the brain and organ tissue. Does consuming cannabis while breastfeeding affect the baby?

Research and Development 68

Research and Development THC Cannabinoids Topical 68

The Cannigma

DECEMBER 1, 2021

The National Institute on Drug Abuse (NIDA) emphasizes that a person’s social environment and personal circumstances represent a critical factor in a person’s risk for harder drug use. the authors compared the safety record of cannabis with that of alcohol. In a 2013 book, Marijuana is Safer: So Why Are We Driving People to Drink?

Research and Development 103

Research and Development Tincture THC Cannabinoids 103

Cannabis Law Report

OCTOBER 6, 2021

LONDON–(BUSINESS WIRE)–Kanabo, one of Europe’s fastest-growing medical cannabis R&D companies that focuses on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers, has signed a partnership agreement with the Medocann Pharma Ltd. ” About Kanabo Group Plc.

Strains 52

Strains Hydroponic Cultivation Extraction 52

Healer

MAY 10, 2019

The safety profile of cannabis in pregnancy, from the little data available, is comparable to other medications in category C (suspected of causing harmful effects on the fetus that may be reversible). Data from human and nonhuman species converge on the ephemeral nature of THC-induced testosterone decline. 1991): 120-123.

Research and Development 52

Research and Development Cannabinoids Data Environment 52

The Cannigma

MARCH 2, 2022

Rather, it’s the patients and the things. I’m picturing like a simple image that you did for us of a first-time patient or she looks like a first-time patient or first-time cannabis consumer, speaking to a bartender, it’s in like a fairly sterile environment, like you mentioned. Rather, it’s the history of0 it.

Wellness and Beauty 52

Wellness and Beauty Cannabis Media Patients 52

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Healer

JUNE 28, 2019

Beyond decreasing the intensity of pain, many patients report that cannabis changes the nature of the pain, making it more bearable and less distracting. Many patients report positive mood, relaxation, laughter, social comfort, time distortion, and the intensification of ordinary experiences (e.g. Abstract: Medical Study .

Cannabinoids 52

Cannabinoids THC Therapy Patients 52